Alkeon Capital Management LLC Arcus Biosciences, Inc. Transaction History

Alkeon Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$26.16 - $41.39 $10.6 Million - $16.8 Million	-407,100 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$17.0 - $32.36 $5.23 Million - $9.96 Million	-307,745 Reduced 43.05%	407,100 $10.6 Million
Q3 2020 Nov 16, 2020	BUY	$17.14 - $25.47 $1.71 Million - $2.55 Million	100,000 Added 16.26%	714,845 $12.3 Million
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $6.91 Million - $18.1 Million	494,845 Added 412.37%	614,845 $15.2 Million
Q1 2020 May 15, 2020	BUY	$8.78 - $19.28 $1.05 Million - $2.31 Million	120,000 New	120,000 $1.67 Million

186

49.2M

204K

149K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.06B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.